Aprea Therapeutics, Inc. - stock earnings
APRE Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -3.2 million USD | 319468 USD |
| 2023Q2 | -3.3 million USD | 249688 USD |
| 2023Q1 | -4.2 million USD | ? USD |
| 2022Q4 | -110.8 million USD | ? USD |
| 2022Q3 | -4.2 million USD | ? USD |
| 2022Q2 | -98.3 million USD | ? USD |
| 2022Q1 | -7.9 million USD | ? USD |
| 2021Q4 | -7.8 million USD | ? USD |
| 2021Q3 | -9.5 million USD | ? USD |
| 2021Q2 | -10.3 million USD | ? USD |
| 2021Q1 | -9.7 million USD | ? USD |
| 2020Q4 | -15.4 million USD | ? USD |
| 2020Q3 | -12.3 million USD | ? USD |
| 2020Q2 | -16.4 million USD | ? USD |
| 2020Q1 | -9.4 million USD | ? USD |
| 2019Q4 | -13.1 million USD | ? USD |
| 2019Q3 | -6.2 million USD | ? USD |
| 2019Q2 | -5.3 million USD | ? USD |
| 2019Q1 | -3.5 million USD | ? USD |
| 2018Q4 | -4.7 million USD | ? USD |
| 2018Q3 | -3.1 million USD | ? USD |
| 2014Q4 | -50976 USD | ? USD |
| 2014Q3 | -215379 USD | ? USD |
| 2013Q4 | -236698 USD | ? USD |
| 2013Q3 | -127003 USD | ? USD |
APRE Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -13.3 million USD | ? USD |
| 2022 | -224.9 million USD | ? USD |
| 2021 | -36.5 million USD | ? USD |
| 2020 | -53.9 million USD | ? USD |
| 2019 | -26.4 million USD | ? USD |
| 2018 | -15.5 million USD | ? USD |
| 2017 | -15.2 million USD | ? USD |
| 2013 | -436215 USD | ? USD |
| 2012 | -254006 USD | ? USD |
| 2007 | -3.5 million USD | 67868 USD |
APRE
Price: $5.20
52 week price:
Earnings Per Share: 12.31 USD
P/E Ratio: 0.42
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 118567
Market Capitalization: 23.2 million